1 active not recruiting, 1 suspended. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Suspended 1 |
| Phase 1 | 1 | Suspended 1 |
Follow Zinlirvimab: new trials by email Literature Review of Zinlirvimab trials Research Report on Zinlirvimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1 ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3 - HIV-1-infection | Phase 1 / Phase 2 | Suspended | National Institute of Allergy and Infectious Diseases (NIAID) | 36 | 2024-04-01 | 2026-09-02 |
| A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection Teropavimab, Zinlirvimab, Lenacapavir Tablet - HIV-1 Infection | Phase 2 | Active not recruiting | Gilead Sciences | 83 | 2023-05-15 | 2026-04-27 |
Gilead Sciences (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (2) · Australia (1) · Brazil (1) · Canada (1) · Puerto Rico (1)